Accendra Health, Inc.ACHNYSE
Loading
Year-over-year net income growth rate
| Period | Value |
|---|---|
| Q4 2025 | 62.52% |
| Q3 2025 | 82.71% |
| Q2 2025 | -3378.74% |
| Q1 2025 | 91.56% |
| Q4 2024 | -2218.84% |
| Q3 2024 | 59.98% |
| Q2 2024 | -45.81% |
| Q1 2024 | -223.07% |
| Q4 2023 | 376.75% |
| Q3 2023 | 77.25% |
| Q2 2023 | -15.66% |
| Q1 2023 | 57.89% |
| Q4 2022 | -564.05% |
| Q3 2022 | -56.31% |
| Q2 2022 | -27.18% |
| Q1 2022 | -6.42% |
| Q4 2021 | -4.88% |
| Q3 2021 | -33.03% |
| Q2 2021 | -5.31% |
| Q1 2021 | 37.14% |
| Q4 2020 | 10.11% |
| Q3 2020 | 182.84% |
| Q2 2020 | -391.23% |
| Q1 2020 | 70.98% |
| Q4 2019 | -3288.15% |
| Q3 2019 | 111.68% |
| Q2 2019 | 25.68% |
| Q1 2019 | 94.62% |
| Q4 2018 | -46240.00% |
| Q3 2018 | 99.69% |
| Q2 2018 | -2342.39% |
| Q1 2018 | -64.56% |
| Q4 2017 | 111.54% |
| Q3 2017 | -46.03% |
| Q2 2017 | 7.22% |
| Q1 2017 | -30.70% |
| Q4 2016 | -9.14% |
| Q3 2016 | 7.63% |
| Q2 2016 | 14.84% |
| Q1 2016 | -24.74% |